Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on June 10, 2025
GSAC Engineering Secures Multi-Year Recurring Revenue Contract
GlobeNewswire
·
June 10, 2025
MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTC: GSAC), a development stage company currently focused on the research, development, and marketing of engineered solutions for the industrial security industries, …
Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology
GlobeNewswire
·
June 10, 2025
Ness-Ziona, Israel, June 10, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present a poster at the European Alliance of …
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium
GlobeNewswire
·
June 10, 2025
SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present …
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
GlobeNewswire
·
June 10, 2025
Dr. Michael Vasconcelles brings more than 25 years of extensive oncology research, development and health technology expertise and corporate executive leadership to Day One Dr. Vasconcelles to drive pipeline creation and execution BRISBANE, Calif., June 10 …
Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
GlobeNewswire
·
June 10, 2025
ISELIN, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the Scottish Medicines …
Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt
GlobeNewswire
·
June 10, 2025
Ashvattha will present Phase 2 data on migaldendranib, a subcutaneous therapy for DME and wet AMD, which could offer a more patient-friendly alternative to current injection-based treatments Company is exploring new technology to normalize VEGF expression, …
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
GlobeNewswire
·
June 10, 2025
BENGALURU, India, June 10, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic …
Vivex® Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer
GlobeNewswire
·
June 10, 2025
MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the appointment of Jon E. Block, Ph.D., an industry luminary with more than 40 years of leadership experience in …
Subscription brand executives ditch digital ad spend for new business models
GlobeNewswire
·
June 10, 2025
CAMBRIDGE, United Kingdom, June 10, 2025 (GLOBE NEWSWIRE) -- Subscription brands are pulling away from digital advertising. According to a new industry-wide study from Bango (AIM: BGO), 48% of subscription leaders report diminishing returns from …
Dimolad Limited Offers Crypto Scam Recovery Services for Victims in the UK
GlobeNewswire
·
June 10, 2025
BROXBURN, Scotland, June 10, 2025 (GLOBE NEWSWIRE) -- In the latest record, Dimolad Limited offers crypto scam recovery services for victims in the UK. As digital currencies revolutionize global finance, they’ve also attracted an alarming proliferation of …
American Tungsten Corp. Identified Multiple Exploration Targets at Ima Mine & Provides an Update on its Technical Report
GlobeNewswire
·
June 10, 2025
Vancouver, BC, June 10, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to provide an update on its exploration plans and independent technical report (the “Technical …
HPQ, Novacium, and Pragma Industries Sign Agreement for Commercial and Industrial Green Hydrogen Production Using METAGENE™ Technology
GlobeNewswire
·
June 10, 2025
MONTREAL and LYON, France, June 10, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, and its French …
HPQ Silicium, Novacium et Pragma Industries concluent un accord de coopération industrielle et commerciale pour la production d’hydrogène vert à l’aide de la technologie METAGENE™
GlobeNewswire
·
June 10, 2025
MONTRÉAL et LYON, France, 10 juin 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’innovation en matériaux avancés et dans la mise au point de …
The Cooperative Logistics Network Celebrates 10 Years of Success at 8th Annual Meeting in Abu Dhabi with 220+ Freight Forwarders in Attendance
GlobeNewswire
·
June 10, 2025
From 28th to 30th May 2025, The Cooperative Logistics Network gathered over 220 freight forwarders from more than 70 countries at the Intercontinental Hotel Abu Dhabi for three days of high-impact networking, business development, and celebration. The …
Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease
GlobeNewswire
·
June 10, 2025
Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease AstraZeneca exercises option to license the first candidate from the IBD joint research program for further development and commercialization …
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement
GlobeNewswire
·
June 10, 2025
MacroGenics received $70 million upfront cash payment from Sagard Healthcare Partners (Sagard) MacroGenics’ cash runway extended through first half of 2027 ROCKVILLE, MD, June 10, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage …
Skyharbour Intersects High-Grade Uranium in Significant 42 m Step Out Hole ML24-15 which Returned 4.74% U3O8 over 1.5 m within 6.4 m of 1.50% U3O8 at Moore Project
GlobeNewswire
·
June 10, 2025
Vancouver, BC , June 10, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce the remaining assay results from its late 2024 diamond drilling program at its 100% owned, 35, …
Brunswick Exploration Once More Outlines a New, Major Dyke at Mirage
GlobeNewswire
·
June 10, 2025
MONTREAL, June 10, 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) is pleased to report a further six drill results from the Winter 2025 program at its Mirage Project. The Mirage Project is located in …
Eviden-built JUPITER supercomputer listed as the most powerful system in Europe and 4th worldwide
GlobeNewswire
·
June 10, 2025
Paris, France – June 10, 2025 – Eviden, the Atos Group product brand leading in advanced computing, cybersecurity products, mission-critical systems and vision AI announces that 57 Eviden-built supercomputers are listed in the TOP500 and in the Green500, …
Le supercalculateur JUPITER conçu par Eviden classé comme le système le plus puissant d'Europe et 4e au niveau mondial
GlobeNewswire
·
June 10, 2025
Paris, France – 10 juin 2025 – Eviden, la branche produit du Groupe Atos leader dans le calcul avancé, les produits de cybersécurité, les systèmes critiques de mission, et l’analyse vidéo augmentée par l’IA annonce aujourd’hui que 57 de ses …